Mice that had been treated with cyclophosphamide and ampicillin were fed with Pseudomonas aeruginosa. These procedures induced an endogenous septicaemia under conditions mimicking the pathophysiology of the disease in man. This model was used to compare the mortality rates in mice infected with P. aeruginosa isolates from various clinical sources. Mortality rates in mice given isolates from blood cultures had a broad range (0—100%), but the mean rate was significantly higher than with isolates from other infection sites. Moreover, blood isolates persisted in the intestines of mice after oral inoculation, whereas most isolates from other sources were gradually eliminated. Most P. aeruginosa isolates from blood culture produced significantly higher levels of exotoxin A and total proteases than isolates from other infection sites. Amongst the blood isolates, all but one of the lethal strains produced large quantities of exotoxin A or total proteases or both. Taken together, the results suggest that the ability of P. aeruginosa to adhere to the intestinal tract and to produce high levels of exo-enzymes may contribute to the development of fatal septicaemia.
PizzoPA,
YoungLS.
Limitations of current antimicrobial therapy in the immunosuppressed host: looking at both sides of the coin. Am J Med1984; 76:Suppl 3A101–110
PollackM,
YoungLS.
Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicaemia in man. J Clin Invest1979; 63:276–286
HirakataY,
TomonoK,
TatedaK et al. Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteraemia. Infect Immun1991; 59:289–294
CrossAS,
SadoffJC,
IglewskiBH,
SokolPA.
Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruqinosa in humans. J Infect Dis1980; 14:538–546
HirakataY,
KakuM,
TomonoK et al. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice. Antimicrob Agents Chemother1992; 36:1198–1203
IglewskiBH,
SadoffJC.
Toxin inhibitors of protein synthesis: production, purification, and assay of Pseudomonas aeruginosa toxin A. Methods Enzymol1979; 60:780–793
HirakataY,
KakuM,
MizukaneR et al. Potential effects of erythromycin on host defence systems and virulence of Pseudomonas aeruginosa. Antimicrob Agents Chemother1992; 36:1922–1927
GriffithSJ,
NathanC,
SelanderRK et al. The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Infect Dis1989; 160:1030–1036
CorreaCMC,
TibanaA,
Gontijo FilhoPP.
Vegetables as a source of infection with Pseudomonas aeruginosa in a university and oncology hospital of Rio de Janeiro. J Hosp Infect1991; 18:301–306
JacksonRJ,
SmithSD,
WadowskyRM,
DePudytL,
RoweMI.
The effect of E. coli virulence on bacterial translocation and systemic sepsis in the neonatal rabbit model. J Pediatr Surg1991; 26:483–486